Morgan Stanley analyst Kristine Liwag upgrades Hexcel (NYSE:HXL) from Underweight to Equal-Weight and raises the price target from $59 to $68.
Have A Look At William Blair’s Top Biotech Picks For 2023
William Blair & Company's report outlined some key themes and significant trends to monitor while entering 2023, providing its top stock ideas for the upcoming 12-month period.